Daniel Erchick, PhD, MPH
Daniel Erchick, PhD, MPH, is an epidemiologist and faculty member in the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. His research focuses on interventions to improve neonatal and infant survival and growth in low-resource settings. His experience includes conduct of community-based randomized controlled trials (RCT) and observational studies. Currently, he works on an RCT to evaluate the impact of a balanced protein energy supplement for mothers during pregnancy on incidence of adverse pregnancy outcomes in rural Nepal. He is also involved in two modeling studies, which, respectively, aim to understand the detailed patterns of neonatal and infant mortality by age and sex and generate global estimates of the phenotypes of vulnerable newborns (i.e., combinations of preterm, small-for-gestational age, and low birth weight).
Connect with Daniel on Twitter: @DanErchick
Resources:
Fulfilling a Promise: Ensuring Immunization for All in Africa
Get to Know Three of our 2024-2025 Social & Behavioral Research Grant Partners (Part 2)
Sabin Vaccine Institute introduces three of the new 2024-2025 cohort of Social and Behavioral Research Grant Partners.
Bridging the Immunization Gap: Community-Driven Strategies for Enhanced Vaccine Coverage
The fifth cohort of the Social & Behavioral Grants program will focus on addressing the challenges faced by zero-dose children and their families.
Get to Know Three of our 2024-2025 Social & Behavioral Research Grant Partners (Part 1)
Sabin Vaccine Institute introduces three of the new 2024-2025 cohort of Social and Behavioral Research Grant Partners.
VARN2023 Conference Report (French)
Quand les communautés dirigent, l’immunisation mondiale réussit